1. Home
  2. Analysis
  3. Carbidopa
  4. Augmentin

Carbidopa and Augmentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carbidopa and Augmentin. Common interactions include arthralgia among females and necrotising fasciitis among males.

The phase IV clinical study analyzes what interactions people who take Carbidopa and Augmentin have. It is created by eHealthMe based on reports of 9 people who take Carbidopa and Augmentin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

9 people who take Carbidopa and Augmentin together, and have interactions are studied.

What is Carbidopa?

Carbidopa has active ingredients of carbidopa. It is often used in parkinson's disease. eHealthMe is studying from 2,480 Carbidopa users for its effectiveness, alternative drugs and more.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 39,139 Augmentin users for its effectiveness, alternative drugs and more.

Number of Carbidopa and Augmentin reports submitted per year:

Carbidopa and Augmentin drug interactions.

Common Carbidopa and Augmentin drug interactions by gender *:

female:

  1. Arthralgia
  2. Malignant neoplasm progression
  3. Metastases to bone
  4. Mitral valve sclerosis
  5. Bone cyst
  6. Bone disorder
  7. Bone pain
  8. Cataract
  9. Fall
  10. Intervertebral disc degeneration

male:

  1. Necrotising fasciitis
  2. Sepsis
  3. Subcutaneous abscess
  4. Chronic kidney disease
  5. Dyspnoea
  6. Renal failure
  7. Respiratory failure

Common Carbidopa and Augmentin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Subcutaneous abscess
  2. Chronic kidney disease
  3. Renal failure
  4. Necrotising fasciitis
  5. Sepsis

60+:

  1. Dyspnoea
  2. Abdominal discomfort
  3. Local swelling
  4. Neuropathy peripheral
  5. Osteomyelitis
  6. Osteonecrosis of jaw
  7. Osteoporosis
  8. Pain
  9. Pain in jaw
  10. Paraesthesia

* Approximation only. Some reports may have incomplete information.

Do you take Carbidopa and Augmentin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Carbidopa and Augmentin interactions:

Browse all drug interactions of Carbidopa and Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Carbidopa side effects:

Browse all side effects of Carbidopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Augmentin side effects:

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Carbidopa interactions:

Browse all interactions between Carbidopa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Augmentin interactions:

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa and amoxicillin; clavulanate potassium (the active ingredients of Carbidopa and Augmentin, respectively), and Carbidopa and Augmentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Carbidopa and Augmentin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.